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ABSTRACT
Background: The association between accelerometer-assessed
physical activity and risk of diabetes remains unclear, especially
among US Hispanic/Latino adults who have lower levels of
physical activity and a higher diabetes burden compared with other
racial/ethnical populations in the country.
Objectives: To examine the association between accelerometer-
assessed physical activity and incident diabetes in a US
Hispanic/Latino population.
Methods: We included 7280 participants of the Hispanic
Community Health Study/Study of Latinos who aged 18–74 y
and free of diabetes at baseline. Data on moderate-to-vigorous
physical activity (MVPA) were collected using a 7-d accelerometer
measurement. Incident diabetes was assessed after a mean ± SD of
6.0 ± 0.8 y using standard procedures including blood tests. RRs
and 95% CIs of diabetes associated with MVPA were estimated
using survey Poisson regressions. The associations of MVPA with
6-y changes in adiposity measures were also examined.
Results: A total of 871 incident cases of diabetes were identified.
MVPA was inversely and nonlinearly associated with risk of diabetes
(P-nonlinearity = 0.006), with benefits accruing rapidly at the lower
end of MVPA range (<30 min/d) and leveling off thereafter. The
association differed by population age (P-interaction = 0.006).
Higher MVPA was associated with lower risk of diabetes among
individuals older than 50 y (RRQ4 versus Q1 = 0.50; 95% CI: 0.35,
0.73; P-trend < 0.001) but not among younger individuals
(RRQ4 versus Q1 = 0.98; 95% CI: 0.66, 1.47; P-trend = 0.92).
An inverse association between MVPA and 6-y gain in waist
circumference was also limited to the older group (P-interaction
with age < 0.001).
Conclusions: Among US Hispanic/Latino adults, baseline
accelerometer-derived MVPA was inversely associated with
incident diabetes only among individuals aged 50 y and older.
Further studies are needed to confirm our findings and to clarify
potential mechanisms underlying the possible age differences
in the MVPA–diabetes association. This study was registered at
clinicaltrials.gov as NCT02060344. Am J Clin Nutr 2020;00:1–10.
Keywords: accelerometers, diabetes, Hispanic American, physical
activity, weight gain
Introduction
Hispanics/Latinos are the largest and the fastest-growing
minority in the United States. They constitute 17% of the nation’s
population, and the proportion is expected to be 30% by 2050 (1).
Compared with other US racial/ethnic groups, Hispanics/Latinos
often have distinct socioeconomic, lifestyle, and genetic char-
acteristics that may contribute to their disproportionately high
burden of metabolic disorders such as obesity and diabetes (2–
4). For example, in a study including nationally representative
samples of US adults, Hispanics were found to have a lower
rate of meeting the recommended levels of physical activity (5)
than other racial/ethnic populations in each year during 2007–
2016 (6).
Lifestyle interventions, including counseling for maintaining
optimal physical activity, diets, and body weight, have been
demonstrated to be effective for diabetes reduction among
high-risk adults (7). Higher physical activity levels have been
extensively associated with lower risk of diabetes in a large
body of cohort studies conducted in populations of different
world regions (8). This evidence has led to several national
organizations (5, 9), including the American Diabetes Associ-
ation (9), to recommend regular physical activity of moderate-
to-vigorous intensities for preventing or delaying the onset of
diabetes or other chronic diseases in adults. Notably, such a
recommendation is largely driven by findings from studies of
middle-aged and older, non-Hispanic populations, and whether
it is similarly applicable to younger populations or populations
of Hispanic/Latino heritages remains open for investigation.
Another concern related to previous studies on physical activity
and diabetes is the sole use of self-reported physical activity
measures, which generally overestimate an individual’s physical
activity [e.g., due to reporting biases arising from imprecise recall
or social desirability (10, 11)].
The Hispanic Community Health Study/Study of Latinos
(HCHS/SOL), a population-based cohort study that recruited
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individuals aged 18–74 y who represented the diverse His-
panic/Latino backgrounds in the United States (12, 13), provides
a unique opportunity to fill this knowledge gap. Thus, we
evaluated the association between moderate-to-vigorous physical
activity (MVPA) as assessed by accelerometers and incident
diabetes in a US Hispanic/Latino population covering the adult
life span. Because habitual physical activity may reduce risk of
diabetes by preventing or attenuating weight gain (5), we further
examined the association of MVPA with longitudinal changes in
adiposity. We hypothesized that higher levels of accelerometer-
assessed MVPA would be associated with lower risk of diabetes.
Methods
Study design and population
The HCHS/SOL is a prospective population-based study of
16,415 Hispanic/Latino adults aged 18–74 y at recruitment
who were living in 4 US metropolitan areas (Bronx, NY;
Chicago, IL; Miami, FL; and San Diego, CA). Recruitment
was designed to occur in stable communities to facilitate
follow-up and reexaminations. As described previously (12, 13),
participants were recruited by using a 2-stage probability sample
design. Following standard protocols, a comprehensive battery
of interviews and a clinical assessment with fasting blood draw
were conducted by trained and certified staff at in-person clinic
visits during 2008–2011 (visit 1). The second visit (visit 2)
period started in October 2014 and concluded in December 2017.
In visit 2, 11,623 cohort members were reexamined to collect
data predictive of cardiopulmonary outcomes and the onset of
diabetes. The study was approved by the institutional review
boards at all participating institutions, and all participants gave
written informed consent.
Assessment of physical activity
During the baseline examination, participants were instructed
to wear an Actical accelerometer (version B-1; model 198–
0200–03; Respironics) for 7 d, positioned above the iliac crest,
with removal only for swimming, showering, and sleeping.
Acceptable technical reliability for counts has been shown for
the accelerometer (14), and detailed information concerning
accelerometer performance and adherence in the HCHS/SOL
has been described elsewhere (15). The accelerometer was
programmed to capture accelerations in counts of 1-min epochs.
Using the Choi algorithm (16), nonwear time was defined as
≥90 consecutive min of zero counts, with allowance of 1 or
2 min of nonzero counts if no counts were detected in a
30-min window upstream and downstream of the 90-min period.
An adherent day was defined as ≥10 h of wear time, and
≥3 adherent days were required for inclusion in the current
analysis. As compared with individuals not adherent to the
accelerometer wear protocols, adherent individuals were older,
were more likely to be employed and be never smokers or
moderate alcohol drinkers, and had a higher diet quality score and
lower adiposity measures (Supplementary Table 1). Differences
in the prevalence of diabetes between adherent and nonadherent
individuals were nonsignificant (P-difference = 0.066). We
used accelerometer counts previously calibrated among adults
of a wide age range (18–59 y) to define sedentary behavior
(<100 counts/min) and MVPA (≥1535 counts/min) (17, 18).
In addition, we explored an alternative definition of MVPA
(≥1065 counts/min) (19).
Ascertainment of outcomes
At both visits 1 and 2, participants were asked to fast for
≥8 h before the examination and consume only water and
necessary medications. Venous blood samples were collected
and analyzed. Details on the laboratory collection, processing,
and analysis are reported elsewhere (3, 20). Plasma glucose
was measured using a hexokinase enzymatic method (Roche
Diagnostics); hemoglobin A1c (HbA1c) was measured in EDTA-
anticoagulated whole blood using a Tosoh G7 automated, non-
porous ion-exchange high-performance liquid chromatography
analyzer (Tosoh Bioscience) (3, 20). Diabetes cases were iden-
tified according to the following American Diabetes Association
criteria applied to centrally measured laboratory tests: 1) fasting
plasma glucose ≥126 mg/dL, 2) post–oral glucose tolerance
test plasma glucose concentration ≥200 mg/dL, and 3) HbA1c
≥6.5%. In addition to laboratory test criteria, information on
self-reported physician diagnosis or current use of antidiabetic
medications was also used to identify additional diabetes cases.
Based on these criteria, participants free of diabetes at visit 1 who
were identified as having diabetes at visit 2 were deemed to be
incident diabetes cases (21).
Measurements of anthropometric indexes and body composi-
tion were performed at both visits 1 and 2. Waist circumference
at the top of the iliac crest and standing height were measured
to the nearest centimeter, and body weight was measured to
the nearest 0.1 kg. BMI was calculated as weight in kilograms
divided by height in meters squared (kg/m2). Body fat mass was
estimated from bioimpedance using a Total Body Composition
Analyzer (model TBF-300A; Tanita Corporation). Longitudinal
changes in adiposity measures, including changes in BMI, waist
circumference, and body fat mass, were computed by subtracting
the measures collected at visit 1 from those at visit 2.
Assessment of covariates
The definitions and methods used for measurements of
other covariates at visit 1 have been reported elsewhere (12).
Briefly, bilingual interviewer-administered questionnaires were
used to collect information on socioeconomic and demographic
characteristics, including Hispanic/Latino background, diet and
lifestyle factors, and medical and family histories. To ascertain
Hispanic/Latino background, participants were asked which
of the following groups best described their heritage: Central
American, Cuban, Dominican, Mexican, Puerto Rican, South
American, >1 background, or other. Dietary energy and the
Alternative Healthy Eating Index (AHEI)–2010 score were
computed by using the National Cancer Institute methodology,
based on data collected by two 24-h dietary recalls with ∼1 mo
apart in addition to a food propensity questionnaire (22).
Statistical analysis
Among the 11,623 reexamined participants, 7280 (2703 men
and 4577 women) were eligible for the analysis of MVPA and
incident diabetes (primary outcome) after excluding participants
who had prevalent diabetes at visit 1 (n = 2541), participants
missing information on diabetes diagnosis at either study visit
(n = 11), and those who did not adhere to the accelerometer pro-
tocol according to the criteria described above (n = 1791) (Sup-
plementary Figure 1). The sample sizes were slightly smaller
for the analyses of changes in adiposity measures (secondary out-
comes), including changes in BMI (n = 7055), waist circumfer-
ence (n = 7036), and body fat mass (n = 6620) (Supplementary
Figure 1).
All analyses incorporated HCHS/SOL complex study design
and sampling weights to account for visit 2 nonresponse and
oversampling of specific population subgroups. Weights were
trimmed and calibrated to 2010 US Census characteristics by
age, sex, and Hispanic/Latino background in each field center’s
target population (12, 13). Additional adjustment was made to
account for missing or incomplete accelerometer data using
inverse probability weighting (23, 24). As a result, the final
weight used in our analysis was the multiplicative product of the
inverse probability weighting weight (to weight the results for the
compliant subset back to the whole HCHS/SOL sample) and the
HCHS/SOL sampling weight (to further weight the results back
to the Hispanic/Latino population in the target areas).
Sex-specific weighted quartiles of MVPA were modeled to
account for the substantial differences in MVPA levels between
men and women. Age-adjusted descriptive characteristics of the
study population across quartiles of MVPA were computed as
means (95% CI) for continuous variables and the data were
compared using a survey linear regression; and as percentages
(95% CI) for categorical variables and the data were compared
using a χ2 test. We used survey Poisson regression models that
offset the lag time between visits 1 and 2 to estimate RRs with
95% CIs of diabetes across MVPA quartile, using the lowest
quartile as reference. Age, sex (where appropriate), study field
center, and Hispanic/Latino background were included in the
minimally adjusted model. The second model further included
the following potential confounders: education, annual household
income, employment status, smoking, alcohol consumption,
AHEI-2010 score, energy intake, history of cardiovascular
disease, number of days wearing accelerometer, and family
history of diabetes. The third (full) model also included sedentary
time. Further exploratory analyses were performed by including
baseline BMI, waist circumference, or body fat mass in the
full model to assess the potential mediation of adiposity on the
MVPA–diabetes association.
Potential nonlinear relation between MVPA and risk of
diabetes was examined using restricted cubic splines with 3 knots
at the 10th, 50th, and 90th percentiles of the distribution. We also
evaluated potential interactions of MVPA with baseline age (≤50
compared with >50 y), sex, BMI (≤30 compared with >30),
Hispanic background (Mexican compared with non-Mexican),
and study field center on risk of diabetes. Additional sensitivity
analyses were performed by 1) excluding self-known incident
diabetes cases (including cases identified solely by blood testing),
2) using 4 convenient categories of MVPA (≤5, >5–15, >15–
30, and >30 min/d) instead of MVPA quartile, and 3) using an
alternate cut-point for accelerometer counts (≥1065 counts/min)
to define MVPA (19).
We next examined associations between MVPA and longitu-
dinal changes in adiposity measures by using a survey linear
TABLE 1 Age-adjusted baseline population characteristics according to quartile of MVPA in US Hispanic/Latino adults1
Quartile for MVPA2
Characteristic All Q1 Q2 Q3 Q4 P value
Number of participants 7280 2059 1783 1798 1640
Age, y 45.9 (45.6, 46.2) 50.0 (49.4, 50.5) 45.9 (45.3, 46.4) 44.4 (43.9, 45.0) 42.6 (42.0, 43.3) <0.001
Male sex, % 47.8 (46.2, 49.4) 48.2 (44.9, 51.5) 48.2 (44.9, 51.6) 48.4 (44.9, 51.8) 49.4 (45.8, 53.0) 0.55
Study field center, %
Bronx 28.3 (25.4, 31.3) 14.6 (11.7, 18.1) 22.5 (19.2, 26.2) 34.7 (30.2, 40.0) 44.8 (40.4, 49.4) <0.001
Chicago 14.5 (12.6, 16.5) 13.9 (11.4, 16.9) 16.6 (14.2, 19.5) 14.1 (11.9, 16.6) 13.6 (11.5, 16.1)
Miami 32.0 (28.0, 36.4) 45.9 (40.4, 51.5) 34.0 (29.1, 39.2) 24.2 (19.5, 29.6) 19.3 (15.4, 23.8)
San Diego 25.2 (22.1, 28.6) 25.6 (21.4, 30.5) 26.9 (23.1, 31.2) 27.0 (22.6, 31.8) 22.3 (18.7, 26.4)
Hispanic/Latino background, %
Central/South American 12.4 (10.9, 14.1) 10.7 (8.9, 12.8) 13.0 (10.8, 15.5) 12.9 (10.7, 15.5) 13.7 (11.1, 16.9) <0.001
Cuban 22.9 (19.8, 26.2) 36.0 (30.9, 41.5) 24.4 (20.3, 28.9) 16.1 (12.6, 20.3) 10.3 (7.9, 13.3)
Dominican 9.6 (8.3, 11.1) 5.5 (4.2, 7.4) 8.2 (6.5, 10.4) 11.2 (9.0, 13.9) 14.2 (11.7, 17.2)
Mexican 35.4 (32.3, 38.6) 32.1 (27.9, 36.5) 37.6 (33.6, 41.9) 37.9 (33.6, 42.4) 35.1 (31.0, 39.4)
Puerto Rican 15.8 (14.1, 17.6) 11.7 (9.2, 14.7) 13.7 (11.4, 16.4) 18.3 (15.5, 21.4) 21.7 (18.6, 25.1)
Other/>1 heritage 3.9 (3.1, 4.7) 3.9 (2.6, 5.9) 3.1 (2.0, 4.9) 3.7 (2.5, 5.2) 5.0 (3.5, 7.1)
Above high school education, % 42.0 (40.1, 44.0) 41.8 (38.2, 45.4) 44.0 (40.0, 48.0) 42.7 (39.2, 46.2) 37.6 (34.2, 41.1) 0.16
Annual household income, %
≤$25,000 52.1 (50.0, 54.3) 51.7 (48.2, 55.2) 50.7 (46.9, 54.7) 51.2 (47.1, 55.3) 57.0 (53.4, 60.6) 0.043
>$25,000 38.2 (36.0, 40.4) 36.7 (33.2, 40.4) 41.6 (36.9, 44.4) 40.1 (36.3, 44.0) 34.4 (31.3, 37.6)
Not reported 9.7 (8.4, 11.1) 11.6 (9.2, 14.5) 8.8 (6.9, 11.0) 8.7 (6.7, 11.2) 8.6 (6.5, 11.4)
Employment status, %
Not employed 47.7 (46.0, 49.5) 52.4 (48.7, 56.1) 46.0 (42.8, 49.2) 46.2 (43.0, 49.4) 45.2 (42.2, 48.3) <0.001
Employed part-time (≤35 h/wk) 17.5 (16.3, 18.7) 14.7 (12.4, 17.3) 17.0 (14.8, 19.5) 17.6 (15.3, 20.2) 20.1 (17.6, 22.8)
Employed full-time (>35 h/wk) 34.8 (33.3, 36.4) 32.9 (29.5, 36.6) 37.0 (34.2, 39.8) 36.2 (33.1, 39.5) 34.7 (31.7, 37.8)
Smoking status, %
Never 61.8 (60.1, 63.4) 57.5 (54.2, 61.7) 64.9 (61.8, 68.0) 60.5 (67.1, 63.8) 62.5 (58.9, 66.0) <0.001
Former 18.1 (16.8, 19.5) 21.0 (18.4, 23.7) 17.6 (15.3, 20.2) 18.6 (16.1, 21.5) 17.8 (15.1, 20.7)
Current 20.1 (18.5, 21.8) 21.5 (18.4, 25.0) 17.5 (14.9, 20.4) 20.9 (18.1, 24.0) 19.7 (16.9, 23.0)
Alcohol consumption, %
None 48.7 (46.6, 50.7) 48.6 (45.1, 52.1) 49.3 (45.2, 53.4) 47.1 (43.4, 50.8) 46.1 (42.2, 50.1) 0.040
Light to moderate3 45.9 (43.9, 47.9) 44.1 (40.7, 47.6) 46.2 (42.2, 50.3) 46.8 (43.2, 50.5) 48.9 (45.1, 52.8)
Heavier 5.4 (4.6, 6.4) 7.3 (5.3, 10.0) 4.5 (3.3, 6.1) 6.1 (4.4, 8.2) 5.0 (3.6, 6.9)
Total energy intake, kcal/d 2020 (1996, 2043) 2073 (2026, 2120) 2054 (2012, 2096) 1995 (1952, 2039) 1956 (1914, 1999) <0.001
AHEI-2010 score 47.0 (46.6, 47.4) 46.2 (45.6, 46.7) 47.4 (46.9, 48.0) 47.3 (46.7, 47.9) 47.1 (46.5, 47.6) 0.033
Accelerometer wearing days 5.1 (5.06, 5.15) 4.9 (4.8, 5.0) 5.1 (5.0, 5.2) 5.2 (5.1, 5.3) 5.2 (5.1, 5.3) <0.001
Sedentary time, h/d 11.7 (11.5, 11.8) 12.1 (11.9, 12.3) 11.7 (11.5, 11.9) 11.7 (11.5, 11.9) 11.2 (11.0, 11.4) <0.001
History of CVD, % 5.4 (4.6, 6.3) 6.5 (4.7, 8.9) 5.5 (4.1, 7.3) 4.3 (2.9, 6.3) 4.6 (3.2, 6.4) <0.001
Family history of diabetes, % 36.8 (35.0, 38.6) 36.8 (33.8, 40.0) 36.3 (33.1, 40.1) 38.2 (34.4, 42.0) 36.6 (33.1, 40.1) 0.43
Baseline prediabetes,4 % 47.2 (45.8, 48.7) 49.2 (46.6, 51.7) 46.6 (43.5, 49.8) 46.2 (42.9, 49.4) 43.3 (39.9, 46.8) <0.001
Baseline BMI, kg/m2 28.9 (28.7, 29.2) 29.7 (29.2, 30.1) 29.3 (28.8, 29.8) 28.8 (28.3, 29.4) 27.5 (27.5, 28.3) <0.001
Baseline waist circumference, cm 96.1 (95.5, 96.6) 97.9 (96.8, 99.0) 97.0 (95.8, 98.1) 95.9 (94.8, 97.0) 93.4 (92.4, 94.5) <0.001
Baseline body fat mass, kg 26.0 (25.5, 26.6) 28.0 (26.9, 29.0) 26.8 (25.6, 28.0) 25.7 (24.7, 26.7) 23.7 (22.8, 24.5) <0.001
1Data are age-adjusted mean (95% CI) for continuous variables or percentage (95% CI) for categorical variables. All results except for age and number
of participants were weighted for survey design, nonresponse, and noncompliance with accelerometer wear protocols. AHEI, Alternative Healthy Eating
Index; CVD, cardiovascular disease; MVPA, moderate-to-vigorous physical activity; Q, quartile.
2Quartiles are sex specific due to the substantially different MVPA levels in men and women; MVPA ranges across quartiles are ≤12.4, 12.5–25.5,
25.6–47.9, and ≥48.0 min/d in men and ≤5.7, 5.8–13.9, 14.0–29.1, and ≥29.2 min/d in women.
3Alcohol consumption of ≤1 drink/d in women or ≤2 drinks/d in men.
4Prediabetes was defined as 1) fasting glucose 100–125 mg/dL, or 2) post–oral glucose tolerance test plasma glucose concentration 140–199 mg/dL, or
3) 5.7% ≤ hemoglobin A1c <6.5%.
regression. Models were adjusted for covariates as described
above and further adjusted for baseline level of the tested
adiposity measure as well as the lag time between visits
1 and 2. The generated results were plotted as marginal
means (95% CI) of changes in adiposity according to MVPA




Weighted median MVPA at baseline was 19.6 (IQR: 8.0–
38.5) min/d for the study population, 25.6 (IQR: 12.5–48.0)
min/d for men, and 14.0 (IQR: 5.7–29.2) min/d for women. The
largest Hispanic/Latino group was Mexican (35.4%), followed
by Cuban (22.8%), Puerto Rican (15.8%), Central or South
American (12.4%), Dominican (9.6%), and other or multiple
backgrounds (3.9%). Age-adjusted characteristics of the study
population according to sex-specific quartile of MVPA are shown
in Table 1. Differences in MVPA distributions according to study
center and Hispanic/Latino background were evident. Higher
MVPA was associated with younger age and lower levels of
total energy intake, sedentary time, and adiposity measures at
baseline. Individuals with higher MVPA were more likely to be
never smokers and less likely to have cardiovascular disease or
prediabetes at baseline.
MVPA and incident diabetes
During a mean ± SD follow-up of 6.0 ± 0.8 y, 871 incident
cases of diabetes (339 in men and 532 in women) were identified.
Age-adjusted incidence rates (per 1000 person-years) were 17.7
(95% CI: 16.0, 19.4) for the whole population included, 19.3
(95% CI: 16.7, 21.8) in men, and 16.3 (95% CI: 14.2, 18.4) in
women.
After the full adjustment for demographic, social-economic,
and lifestyle factors including sedentary time (model 3), as
shown in Figure 1, there was a significant, nonlinear, and
inverse association between MVPA and risk of diabetes (P-
nonlinearity = 0.006). Diabetes risk decreased sharply with
increasing MVPA up to the level of ∼30 min/d, with risk
reduction leveling off thereafter. Compared with the first MVPA
quartile, the multivariable-adjusted RRs of diabetes across the
second to fourth quartiles of MVPA were 0.76 (0.59, 0.97), 0.67
(0.51, 0.89), and 0.78 (0.57, 1.05).
We performed stratified analyses with multivariable adjust-
ment (model 3 in Table 2). The association of MVPA with risk
of diabetes did not vary significantly by sex, BMI, Hispanic
background, or study field center (P-interaction > 0.20).
However, there was evidence that the association was modified
by age (P-interaction = 0.006). MVPA was not associated with
risk of diabetes among younger individuals (≤50 y; 418 incident
cases; RRQ4 versus Q1 = 0.98; 95% CI: 0.66, 1.47; P-trend = 0.92).
Among older individuals (>50 y; 453 incident cases), there was a
strong nonlinear and inverse association (P-nonlinearity < 0.001)
(Figure 1), with those in the highest MVPA quartile having 50%
lower risk of diabetes as compared with those in the lowest
quartile (RR = 0.50; 95% CI: 0.35, 0.73; P-trend < 0.001)
(Table 2). The age-specific difference in the associations of
MVPA with risk of diabetes appeared more evident in men than in
women (P-interaction with age: 0.006 in men and 0.41 in women)
(Table 2). Furthermore, the inverse association in the older group
was attenuated only slightly in an exploratory analysis with
additional adjustment for baseline waist circumference (model 4
in Table 2) or BMI or body fat mass (data not shown).
The age-specific association between MVPA and risk of dia-
betes was observed for both individuals of Mexican background
and non-Mexican populations (Supplementary Table 2). When
4 convenient categories instead of MVPA quartile were used,
the association was similarly age dependent (Supplementary
Table 3). After excluding 388 cases who were aware of their
diabetes diagnosis before the follow-up visit, MVPA remained
inversely associated with risk of diabetes in the older group (249
incident cases; RRQ4 versus Q1 = 0.60; 95% CI: 0.37, 0.97; P-
trend = 0.011) but not in the younger group (234 incident cases;
RRQ4 versus Q1 = 1.04; 95% CI: 0.64, 1.70; P-trend = 0.69). We
performed an additional analysis based on 4 age groups. Age-
adjusted incidence rates (per 1000 person-years) were 9.4 (95%
CI, 7.3, 11.5), 22.9 (95% CI: 17.9, 27.8), 27.3 (95% CI: 22.0,
32.6), and 28.6 (95% CI: 22.5, 34.7) among individuals aged
≤40, 41–50, 51–60, and >60 y, respectively. Higher MVPA
was associated with substantially lower risk of diabetes in the
2 subgroups of older individuals (P-trend ≤ 0.008), but there
were no associations among either group including younger
individuals (P-trend > 0.70) (P-interaction with age = 0.017)
(Supplementary Table 4).
We performed an additional analysis in which MVPA was
defined by an alternate accelerometer count (≥1065 counts/min).
Correlation between the original and the new MVPA variables
was substantial (Pearson r = 0.93). Weighted medians for the
new MVPA were 32.8 (IQR: 16.8–57.6) min/d for the study
population, 43.3 (IQR: 24.0–70.2) min/d for men, and 24.8
(IQR: 12.4–43.5) min/d for women. Similar to the original
MVPA variable, the new MVPA variable was associated with
lower risk of diabetes among individuals older than 50 y
(RRQ4 versus Q1 = 0.53; 95% CI: 0.35, 0.79; P-trend < 0.001) but
not among younger individuals (RRQ4 versus Q1 = 1.01; 95% CI:
0.66, 1.56; P-trend = 0.92) (P-interaction with age = 0.006)
(Supplementary Table 5).
MVPA and changes in adiposity
During the 6-y follow-up, on average, the study population
experienced an increment of 0.85 (95% CI: 0.72, 0.99) in BMI,
2.76 (95% CI: 2.41, 3.11) cm in waist circumference, and 2.03
(95% CI: 1.67, 2.39) kg in body fat mass. Younger (≤50 y)
relative to older individuals had greater increases in BMI [1.03
(95% CI: 0.87, 1.19) compared with 0.20 (95% CI: 0.05, 0.34)],
waist circumference [3.13 (95% CI: 2.71, 3.55) compared with
1.41 (95% CI: 1.03, 1.78) cm], and body fat mass [2.51 (95% CI:
2.07, 2.95) compared with 0.18 (95% CI: −0.09, 0.44) kg].
Informed by the substantial differences in the associations of
MVPA with weight change by age (all P-interaction with age
≤0.006), age-specific associations for the secondary outcomes
of adiposity changes were plotted (Figure 2). For the younger
group, higher MVPA was significantly associated with larger
increases in BMI (P-trend = 0.004), waist circumference (P-
trend = 0.046), and body fat mass (P-trend = 0.001). Conversely,
MVPA was not associated with changes in BMI or body fat
mass but was significantly associated with a smaller waist
circumference gain (P-trend = 0.006) in the older group.
Such age-specific differences in the association of MVPA with
adiposity changes appeared more evident in men than in women
(Supplementary Figure 2) and were observed for both Mexican-
and non-Mexican-heritage groups (Supplementary Figure 3). In
an additional analysis based on the aforementioned 4 age groups,
MVPA tended to be positively associated with adiposity changes
in the 2 groups of younger individuals, but the associations
appeared inverse or null in the other 2 groups of older individuals
(P-interaction with age ≤0.011) (Supplementary Figure 4).
Discussion
In this population-based cohort of US Hispanic/Latino adults,
we initially found a nonlinear inverse association between
FIGURE 1 Restricted cubic splines examining nonlinear relation between MVPA and risk of diabetes. All data were included in the analyses and
results for MVPA <90 min/d (the 95th percentile for the MVPA of the study population) are shown for presentation purpose. MVPA of (at least)
21.4 min/d (or 150 min/wk) recommended by the “2018 Physical Activity Guidelines for Americans” was used as the reference. Results were from
multivariable survey Poisson regression models that were weighted for survey design, nonresponse, and noncompliance with accelerometer wear protocols
and further adjusted for covariates listed for model 3 in Table 2. The analysis included 4420 individuals aged ≤50 y and 2860 individuals aged
>50 y. MVPA, moderate-to-vigorous physical activity.
accelerometer-derived MVPA at baseline and risk of diabetes
after 6 y of follow-up, with the reduction of diabetes risk accruing
rapidly at the lower end of the MVPA range (<30 min/d). Such
a nonlinear pattern, which has been frequently depicted in other
racial/ethnic populations (25), agrees with the statement by the
2018 Physical Activity Guidelines for Americans that “there is
no threshold (of MVPA) that must be exceeded before benefits
begin to occur” (5). Making use of the broad age range of
our study, further analyses revealed substantial differences in
the association of MVPA with risk of diabetes by age, with a
strong inverse association in older individuals (age >50 y) but
no association in younger individuals (age ≤50 y).
To our knowledge, this is the first study examining
accelerometer-derived physical activity in relation to incident
diabetes. While previous cohort studies have extensively
documented an inverse association between self-reported
physical activity and risk of diabetes (8), they included
mostly middle-aged and older, non-Hispanic populations. In
2 prospective studies of US multiethnic populations, higher
levels of self-reported physical activity were associated with
a lower risk of diabetes for Hispanics in the Women’s Health
Initiative study (26) but not in the Multi-Ethnic Study of
Atherosclerosis (27), although the sample size of Hispanics in
the latter study was relatively small.
There have been limited cohort studies assessing associations
of physical activity with diabetes risk by different age groups,
and results were not clear (28, 29). Results from some inter-
vention trials, including high-risk participants, have indicated
that lifestyle interventions may be particularly effective for
relatively older people in terms of diabetes prevention (30–32).
In the Finnish Diabetes Prevention Study (30), intensive lifestyle
intervention with advice to exercise for >4 h/wk significantly
reduced diabetes risk by 51% among participants aged 51–
61 y and by 64% among those older than 61 y, respectively,
whereas the intervention conferred no benefits for those younger
than 51 y (P-interaction with age = 0.013). Similar age-varying
effects of intensive lifestyle on diabetes reduction were observed
in another trial conducted among the US population (Diabetes
Prevention Program) (31, 32). However, because both healthful
diets and regular physical activity were emphasized in the trials,
it is unclear whether the stronger benefits for older individuals
could be partially attributable to their greater adherence to the
recommendations on physical activity.
In our study, the associations between baseline MVPA and
longitudinal changes in adiposity also appeared age dependent.
Higher MVPA was associated with a smaller waist circumference
gain in the older group but was unexpectedly associated with
larger gains in all the examined adiposity measures in the younger
group. Several previous studies (33–38) that had a smaller sample
size and shorter duration assessed how accelerometer-derived
MVPA may be associated with adiposity changes. Most of these
studies included relatively young individuals [i.e., ≤50 y (33–36,
38)] and suggested no association despite few exceptions (33, 38).
Our findings may not refute the beneficial roles of physical
activity in the prevention of diabetes in the younger population
but instead may reflect challenges in capturing usual physical
activity by accelerometers among younger adults. Despite as-
sessing physical activity objectively, accelerometer measurement
has limitations in terms of determining certain physical activity
types that are more common among younger individuals (39). For
example, physical activity in water such as swimming was not
recorded. Other types of physical activity that would be expected
to be poorly captured by the hip-worn accelerometer include
work-related exertion (e.g., lifting and using tools), resistance
TABLE 2 Association between MVPA and incident diabetes according to age groups in US Hispanic/Latino adults1
Quartile for MVPA2
Q1 Q2 Q3 Q4 P-trend
Men and women
≤50 y
Cases/participants 113/974 107/1119 94/1164 104/1163
Incidence rate3 13.5 (10.1, 16.9) 13.1 (9.3, 17.0) 13.5 (8.9, 18.1) 16.3 (11.1, 21.5)
Model 1, RR (95% CI) 1.00 (reference) 0.85 (0.59, 1.23) 0.77 (0.52, 1.14) 0.92 (0.64, 1.33) 0.67
Model 2, RR (95% CI) 1.00 (reference) 0.83 (0.57, 1.21) 0.76 (0.52, 1.12) 0.94 (0.66, 1.33) 0.72
Model 3, RR (95% CI) 1.00 (reference) 0.85 (0.59, 1.23) 0.78 (0.53, 1.16) 0.98 (0.66, 1.47) 0.92
Model 4, RR (95% CI) 1.00 (reference) 0.88 (0.61, 1.28) 0.81 (0.55, 1.21) 1.12 (0.73, 1.69) 0.68
>50 y
Cases/participants 207/1085 96/664 86/634 64/477
Incidence rate3 34.9 (28.9, 40.8) 22.1 (16.3, 28.0) 22.7 (16.1, 29.3) 20.6 (13.1, 28.0)
Model 1, RR (95% CI) 1.00 (reference) 0.62 (0.45, 0.87) 0.54 (0.39, 0.76) 0.47 (0.33, 0.66) <0.001
Model 2, RR (95% CI) 1.00 (reference) 0.65 (0.48, 0.89) 0.59 (0.42, 0.80) 0.49 (0.35, 0.68) <0.001
Model 3, RR (95% CI) 1.00 (reference) 0.66 (0.48, 0.90) 0.59 (0.42, 0.84) 0.50 (0.35, 0.73) <0.001
Model 4, RR (95% CI) 1.00 (reference) 0.70 (0.51, 0.96) 0.65 (0.45, 0.92) 0.56 (0.38, 0.82) <0.001
Men
≤50 y
Cases/participants 45/392 39/417 34/431 48/437
Incidence rate3 14.4 (8.8, 19.9) 11.6 (6.0, 17.2) 16.4 (8.0, 24.8) 22.3 (13.8, 30.7)
Model 1, RR (95% CI) 1.00 (reference) 0.73 (0.41, 1.28) 0.75 (0.43, 1.32) 1.02 (0.57, 1.82) 0.81
Model 2, RR (95% CI) 1.00 (reference) 0.75 (0.42, 1.33) 0.76 (0.45, 1.26) 1.04 (0.62, 1.76) 0.76
Model 3, RR (95% CI) 1.00 (reference) 0.75 (0.42, 1.33) 0.76 (0.43, 1.32) 1.04 (0.55, 1.96) 0.84
Model 4, RR (95% CI) 1.00 (reference) 0.75 (0.42, 1.36) 0.77 (0.44, 1.34) 1.15 (0.59, 2.24) 0.64
>50 y
Cases/participants 83/398 37/237 29/215 24/176
Incidence rate3 42.2 (32.4, 52.0) 22.6 (13.9, 31.4) 22.9 (11.9, 33.8) 24.7 (12.4, 37.0)
Model 1, RR (95% CI) 1.00 (reference) 0.52 (0.32, 0.85) 0.46 (0.27, 0.77) 0.44 (0.26, 0.75) <0.001
Model 2, RR (95% CI) 1.00 (reference) 0.54 (0.35, 0.82) 0.50 (0.30, 0.84) 0.48 (0.28, 0.81) 0.001
Model 3, RR (95% CI) 1.00 (reference) 0.52 (0.34, 0.81) 0.48 (0.27, 0.86) 0.45 (0.25, 0.80) 0.003
Model 4, RR (95% CI) 1.00 (reference) 0.57 (0.37, 0.89) 0.54 (0.30, 0.97) 0.50 (0.28, 0.88) 0.001
Women
≤50 y
Cases/participants 68/582 68/702 60/733 56/726
Incidence rate3 13.5 (9.0, 18.1) 14.5 (9.9, 19.0) 11.1 (7.2, 15.0) 10.7 (6.6, 14.8)
Model 1, RR (95% CI) 1.00 (reference) 0.98 (0.60, 1.59) 0.77 (0.47, 1.28) 0.77 (0.48, 1.24) 0.20
Model 2, RR (95% CI) 1.00 (reference) 0.98 (0.62, 1.56) 0.76 (0.46, 1.25) 0.75 (0.47, 1.17) 0.13
Model 3, RR (95% CI) 1.00 (reference) 1.01 (0.64, 1.61) 0.80 (0.48, 1.31) 0.81 (0.48, 1.39) 0.31
Model 4, RR (95% CI) 1.00 (reference) 1.17 (0.74, 1.85) 0.84 (0.49, 1.45) 0.99 (0.57, 1.72) 0.65
>50 y
Cases/participants 124/687 59/427 57/419 40/301
Incidence rate3 29.3 (22.2, 36.4) 21.7 (14.3, 29.2) 22.8 (15.4, 30.2) 15.8 (9.5, 22.1)
Model 1, RR (95% CI) 1.00 (reference) 0.74 (0.48, 1.12) 0.64 (0.42, 0.97) 0.48 (0.29, 0.77) 0.002
Model 2, RR (95% CI) 1.00 (reference) 0.73 (0.48, 1.09) 0.63 (0.43, 0.93) 0.46 (0.28, 0.73) 0.001
Model 3, RR (95% CI) 1.00 (reference) 0.77 (0.50, 1.17) 0.69 (0.46, 1.03) 0.53 (0.32, 0.89) 0.012
Model 4, RR (95% CI) 1.00 (reference) 0.82 (0.54, 1.24) 0.76 (0.50, 1.13) 0.61 (0.36, 1.02) 0.053
1Results were from multivariable survey Poisson regression models that were weighted for survey design, nonresponse, and noncompliance with
accelerometer wear protocols. Model 1 included study field center, baseline age, sex (where appropriate), and Hispanic/Latino background. Model 2 included
the covariates in model 1 and education (no high school, at most high school, greater than high school), annual household income (≤$10,000;
$10,001–$25,000; $25,001–$50,000; $50,001–$75,000; ≥$75,001), employment status (retired and not employed, not retired and not employed, part-time
employed, full-time employed), smoking (never, former, current ≤10 pack-years, current >10 pack-years), alcohol consumption (never, former, current ≤2
drinks/d in men or ≤1 drink/d in women, current >2 drinks/d in men or >1 drink/d in women), Alternative Healthy Eating Index–2010 score (continuous),
total energy intake (kcal/d), history of cardiovascular disease (yes, no), number of days wearing accelerometer, and family history of diabetes (yes, no).
Model 3 included the covariates in model 2 and sedentary time (h/d). Model 4 included the covariates in model 3 and baseline waist circumference (cm).
MVPA, moderate-to-vigorous physical activity; Q, quartile.
2Quartiles are sex specific due to the substantially different MVPA levels in men and women. MVPA ranges across quartiles are ≤12.4, 12.5–25.5,
25.6–47.9, and ≥48.0 min/d in men and ≤5.7, 5.8–13.9, 14.0–29.1, and ≥29.2 min/d in women, respectively. P values for interaction between MVPA quartile
and age on diabetes risk were 0.006 for the whole study population, 0.006 for men, and 0.41 for women based on model 3, and the corresponding values
based on model 4 were 0.014, 0.008, and 0.53.
3Age-adjusted incidence rate per 1000 person-years.
FIGURE 2 Association between MVPA and prospective changes in adiposity according to age group. Results were from multivariable survey linear
regression models that were weighted for survey design, nonresponse, and noncompliance with accelerometer wear protocols. In addition to the covariates
listed in the model 3 of Table 2, results were further adjusted for lag time between the 2 study visits and baseline level of the examined adiposity measure.
The numbers of individuals by age group (≤50/>50 y) were 4272/2783 (BMI changes), 4261/2775 (waist changes), or 4077/2543 (fat mass changes). MVPA,
moderate-to-vigorous physical activity.
training, and cycling. It is also uncertain whether the study
participants continued to wear the accelerometer during team
athletics events such as soccer, during which device wearing may
become inconvenient.
Reproducibility of usual physical activity assessed by a single
7-d accelerometer measurement has been shown to be acceptable
in older individuals (40, 41) but remains uncertain in younger
adults. Owning to the major life events (e.g., starting job, getting
married, and having children) as well as apparent weight gains
across early to middle adulthood, younger individuals may have
an intermittent pattern of physical activity that is inaccurately
captured by a single measurement (31, 42).
It is also known that, in the absence of other lifestyle changes
such as improved diet, the benefits of being physically active
alone on long-term weight loss are typically modest (if not null)
(43–45). Thus, the age-varying association of MVPA with risk
of diabetes or with changes in adiposity may also involve age-
specific differences in other physical activity–associated lifestyle
behaviors (e.g., caloric restriction and diet quality) that play
critical roles in diabetes prevention and weight regulation (44,
46). Finally, age-related biologic variation may have contributed
to the stronger association of MVPA with risk of diabetes
observed for the older group (47). Aging is accompanied by
elevated abdominal and visceral fat, leading to various metabolic
abnormalities, including insulin resistance and hyperinsulinemia
(47). Because regular physical activity may improve insulin
sensitivity and glycemic control beyond habitual diet and weight
loss (47, 48), being active may be particularly favorable for
diabetes prevention for relatively older people who are prone
to metabolic dysfunctions, even in the absence of weight
reduction.
Strengths of our study include the representative population
sample of US Hispanics and Latinos across the adult life span,
the adjustment for both nonresponse in the study recruitment or
follow-up phases and noncompliance with accelerometer wear
protocols, and the ascertainment of diabetes according to multiple
standard procedures. Some limitations to our study need to be
acknowledged. Despite the relatively comprehensive measure-
ments of and statistical adjustment for a wide range of covariates,
potential influence of unmeasured/unknown confounding on our
results cannot be completely excluded. One may argue that
the lack of association between MVPA and risk of diabetes
among younger individuals may be attributable to the much
lower incidence of diabetes in this group. However, the lack
of association remained among individuals aged 41–50 y who
had a much higher incidence of diabetes than those aged ≤40 y
(Supplementary Table 4). Other limitations of our study include
the low ability of the accelerometer to collect specific physical
activity data and the single 7-d accelerometer measurement.
Future studies using repeated accelerometer data will shed further
light on how sustained physical activity over a long period may
affect health risk, including risk of diabetes, especially among
younger individuals.
In summary, our study of US Hispanic/Latino adults suggests
an age-varying association between baseline accelerometer-
derived MVPA and risk of diabetes, with a strong inverse
association limited to individuals aged 50 y and older. Additional
studies of accelerometer-derived physical activity are needed
to confirm our findings and to clarify potential mechanisms
underlying the possible age differences in the MVPA–diabetes
association.
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